A Safety and Tolerability Study of Human Forebrain Neural Progenitor Cells Injection (hNPC01) in Subjects With Chronic Ischemic Stroke
Conditions: Chronic Ischemic Stroke Interventions: Drug: hNPC01 Sponsors: Hopstem Biotechnology Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
Relma-cel for Moderate to Severe Active Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus Interventions: Drug: Relma-cel Sponsors: Shanghai Ming Ju Biotechnology Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
NodThera ’s NLRP3 Inhibitor NT-0796 Reverses Neuroinflammation in Parkinson’s Disease Phase Ib/IIa Trial
BOSTON, MA, March 7, 2024– NodThera, a leading clinical-stage biotech developing brain-penetrant NLRP3 inflammasome inhibitors to treat chronic inflammatory diseases, today announces positive data from its Phase Ib/IIa study... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 7, 2024 Category: Pharmaceuticals Source Type: clinical trials
Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Conditions: Relapsed and Refractory B-cell Non-Hodgkin Lymphoma Interventions: Biological: LUCAR-G39P cells product Sponsors: The First Affiliated Hospital with Nanjing Medical University; Nanjing Legend Biotech Co. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)
Conditions: Lupus Erythematosus; Systemic Lupus Erythematosus; SLE (Systemic Lupus); Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Granulomatous Polyangiitis; Microscopic Polyangiitis Interventions: Biological: SC291 Sponsors: Sana Biotechnology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials
A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adults
Conditions: Respiratory Syncytial Virus Infections Interventions: Biological: Bivalent RSV Vaccine (IN006); Biological: Placebo Sponsors: Shenzhen Shenxin Biotechnology Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Study Evaluating SC262 in Subjects With r/r B-cell Malignancies (VIVID)
Conditions: Non Hodgkin ' s Lymphoma; Large B-cell Lymphoma Interventions: Drug: SC262 Sponsors: Sana Biotechnology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials
HealiAid in the Treatment of Different Wounds
Conditions: Venous Ulcers; Bedsores; Diabetic Foot Wound; Burn Wound Interventions: Device: HealiAid Collagen Wound Dressing Sponsors: Maxigen Biotech Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
A Study of SKB264 Versus Investigator's Choice Chemotherapy in Patients With Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer
Conditions: Triple Negative Breast Cancer Interventions: Drug: SKB264; Drug: Paclitaxel; Drug: Nab-paclitaxel; Drug: Capecitabine; Drug: Eribulin; Drug: Carboplatin Sponsors: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety Evaluation of PLB1004 in Patients With Non-squamous NSCLC Harboring EGFR Exon 20 Insertion.
Conditions: Non-Small-Cell Lung Cancer Interventions: Drug: PLB1004; Drug: Pemetrexed+ （carboplatin or Cisplatin）with or without Sintilimab Sponsors: Avistone Biotechnology Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
An Exploratory Clinical Study to Evaluate the Safety and Efficacy of NK Cells (Combined With Standard Therapy) in the Treatment of Solid Tumor Patients
Conditions: Solid Tumors (Pancreatic Cancer, Esophageal Cancer, Gastric Cancer, Cholangiocarcinoma, Lung Cancer and Ovarian Cancer) Interventions: Drug: Allogeneic NK （CCT-ANK-11) Sponsors: Escure Biotechnology Corp; Beijing Kejing Biotechnology Corp. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
A Phase I/II Clinical Study of the KL003 Cell Injection in β-Thalassemia Major Participants
Conditions: Transfusion-dependent Beta-Thalassemia Interventions: Drug: KL003 Cell Injection Drug Product Sponsors: Kanglin Biotechnology (Hangzhou) Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
An Evaluation of LY007 Cell Injection for r/r B-NHL
Conditions: B-NHL Interventions: Drug: LY007 Sponsors: Shanghai Longyao Biotechnology Inc., Ltd.; The First Affiliated Hospital with Nanjing Medical University; Ruijin Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
CD19-BAFF CAR-T Cells Therapy for Patients With Autoimmune Diseases
Conditions: Autoimmune Diseases Interventions: Biological: CD19-BAFF Targeted CAR T-cells Sponsors: Zhejiang University; Shanghai YaKe Biotechnology Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Post-marketing Study of Lyophilized Nasal Spray Live Attenuated Influenza Vaccine
Conditions: Influenza Prevention Interventions: Biological: Influenza Vaccine, Live, Nasal, Freeze-dried; Other: Sterile water for inhalation Sponsors: Changchun BCHT Biotechnology Co.; Hu Bei province Center for Disease control and prevention; The Inner Mongolia Autonomous Region Center for Disease Control and Prevention Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
